Capital Research Global Investors 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-07-09 12:27 pm Sale |
2021-07-09 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
Capital Research Global Investors | 466,422 2.800% |
-1,424,365 (-75.33%) |
Filing |
| 2021-02-16 1:27 pm Purchase |
2021-02-16 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
Capital Research Global Investors | 1,890,787 12.200% |
193,668 (+11.41%) |
Filing |